Researchers at the University of Massachusetts Medical School are trying to develop an alternative way to prevent Lyme disease infection: a drug that could be administered to those at risk annually, just before tick season, the Boston Globe reported.
Though it sounds like the flu shot, the drug is not a vaccine, which activates the immune system against an invader. Instead, it is a pre-exposure prophylaxis, a molecule ready to kill bacteria immediately, similar to pills taken to ward off malaria when traveling abroad. “You take the medicine before you’re going to be exposed,” says lead researcher Mark Klempner, executive vice chancellor at MassBiologics, the nonprofit drug research and manufacturing arm of UMass.
Klempner and colleagues presented positive results from mouse studies at two infectious disease conferences last month, but the details have yet to be reviewed by other scientists or published.
Click here to read the entire article
Source: Boston Globe
Latest from Pest Control Technology
- How to Take Advantage of Networking in the Pest Control Industry
- Rat Damage to Vehicles Rises as Temperatures Grow Colder
- CSI: Termites
- Drowning in the Details? Seven Steps to Overcoming the Urge to Micromanage
- Ground Dove Population Increases on Ulong Island Following Removal of Invasive Rats
- Miller Pest Solutions Promotes Keith Johnson to External Operations Director
- Anticimex Carolinas Family of Brands Sponsors Salvation Army Angel Tree Program
- Guest Feature: Insight Canada’s Path to Sustainable Success in Quebec
